Harrow, Inc.
HROWNasdaqCIK 1360214HealthcareFiscal year ends Dec 31
Reports and events: 371 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0507:32 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-064749 |
| 2026-09-0416:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-041569 |
| 2026-08-1016:28 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-055271 |
| 2026-08-1016:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036865 |
| 2026-08-0607:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036256 |
| 2026-06-2207:30 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-029486 |
| 2026-06-0309:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026983 |
| 2026-05-1116:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022254 |
| 2026-05-1116:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-022227 |
| 2026-04-2416:05 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001493152-26-018912 |
| 2026-03-2716:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-013199 |
| 2026-03-2416:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012389 |
| 2026-03-2408:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012279 |
| 2026-03-1008:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009452 |
| 2026-03-0216:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-008562 |
| 2026-03-0216:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008552 |
| 2026-02-0207:30 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-004635 |
| 2025-11-1808:00 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-023988 |
| 2025-11-1017:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021562 |
| 2025-11-1017:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021555 |
| 2025-10-0607:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-017007 |
| 2025-10-0107:39 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-25-016473 |
| 2025-09-2907:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-015878 |
| 2025-09-2616:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-015712 |
| 2025-09-2607:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-015054 |
| 2025-09-1916:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-25-014242 |
| 2025-09-1216:48 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013268 |
| 2025-09-0907:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-012840 |
| 2025-09-0808:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-012778 |
| 2025-08-2507:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-025336 |
| 2025-08-1116:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-022980 |
| 2025-08-1116:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-022971 |
| 2025-07-1707:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-019976 |
| 2025-06-2006:01 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-015665 |
| 2025-06-0907:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-014234 |
| 2025-05-0816:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009263 |
| 2025-05-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009247 |
| 2025-04-2508:00 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001641172-25-006102 |
| 2025-04-0721:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-003110 |
| 2025-03-2716:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000925 |
| 2025-03-2716:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000915 |
| 2025-03-1716:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-010589 |
| 2025-01-2107:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-002913 |
| 2024-11-1406:23 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045295 |
| 2024-11-1406:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045283 |
| 2024-10-2807:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-042600 |
| 2024-09-0907:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-035390 |
| 2024-08-0717:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030575 |
| 2024-08-0716:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030563 |
| 2024-06-2607:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-025198 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:30 ET. Listed shows no prices and gives no investment advice.